General
Lupin Neurosciences is committed to working with Healthcare Professionals to develop science-based solutions that stretch beyond access to lifechanging treatment options to optimize patient care in underserved neurological diseases.
2025 Congresses
- Real-world and recent clinical trials in NDM show consistent myotonia improvements with mexiletine
- Mexiletine Paediatric Investigation Plan, PIP4 Study: Efficacy findings in children with myotonia
- Mexiletine Paediatric Investigation Plan, PIP4 study: safety and pharmacokinetic findings in children with myotonia
- Development and validation of the Myotonia symptom checker